{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:08:14Z","timestamp":1788538094117,"version":"build-2803163510"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H04997"],"award-info":[{"award-number":["22H04997"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22F22072"],"award-info":[{"award-number":["22F22072"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H04925"],"award-info":[{"award-number":["22H04925"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004298","name":"Secom Science and Technology Foundation","doi-asserted-by":"publisher","award":["2025"],"award-info":[{"award-number":["2025"]}],"id":[{"id":"10.13039\/501100004298","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-67745-x","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T10:02:33Z","timestamp":1769421753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["CXCR4 induces memory formation over exhaustion in CAR-T cells to achieve durable leukemia targeting"],"prefix":"10.1038","volume":"17","author":[{"given":"Ari","family":"Itoh-Nakadai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minggao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiho","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Bibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Tomizawa-Murasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saera","family":"Fujiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9575-2127","authenticated-orcid":false,"given":"Emi","family":"Kanamaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kajita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8128-6201","authenticated-orcid":false,"given":"Yoshinari","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2295-2873","authenticated-orcid":false,"given":"Miki","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9261-711X","authenticated-orcid":false,"given":"Jonathan","family":"Moody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7564-157X","authenticated-orcid":false,"given":"Makoto","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0441-393X","authenticated-orcid":false,"given":"Shinsuke","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumya","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanae","family":"Amitani-Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Sorimachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahoko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuharu","family":"Hanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4333-0224","authenticated-orcid":false,"given":"Kazushige","family":"Katsura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehisa","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Negishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7997-2149","authenticated-orcid":false,"given":"Mikako","family":"Shirouzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8910-0021","authenticated-orcid":false,"given":"Yuho","family":"Najima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1736-7592","authenticated-orcid":false,"given":"Keiyo","family":"Takubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung Chau","family":"Hon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5952-5926","authenticated-orcid":false,"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihide","family":"Momozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7202-7243","authenticated-orcid":false,"given":"Piero","family":"Carninci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard D.","family":"Shultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoriko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0489-2352","authenticated-orcid":false,"given":"Michiel","family":"de Hoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4037-3533","authenticated-orcid":false,"given":"Jay W.","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8717-1237","authenticated-orcid":false,"given":"Fumihiko","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"67745_CR1","doi-asserted-by":"publisher","first-page":"9053","DOI":"10.1158\/0008-5472.CAN-10-2880","volume":"70","author":"Y Zhao","year":"2010","unstructured":"Zhao, Y. et al. Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor. Cancer Res 70, 9053\u20139061 (2010).","journal-title":"Cancer Res"},{"key":"67745_CR2","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","volume":"368","author":"SA Grupp","year":"2013","unstructured":"Grupp, S. A. et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N. Engl. J. Med 368, 1509\u20131518 (2013).","journal-title":"N. Engl. J. Med"},{"key":"67745_CR3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","volume":"385","author":"DW Lee","year":"2015","unstructured":"Lee, D. W. et al. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial. Lancet 385, 517\u2013528 (2015).","journal-title":"Lancet"},{"key":"67745_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1056\/NEJMoa1709919","volume":"378","author":"JH Park","year":"2018","unstructured":"Park, J. H. et al. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia. N. Engl. J. Med 378, 449\u2013459 (2018).","journal-title":"N. Engl. J. Med"},{"key":"67745_CR5","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil, E. et al. Genomic classification and prognosis in acute myeloid leukemia. N. Engl. J. Med 374, 2209\u20132221 (2016).","journal-title":"N. Engl. J. Med"},{"key":"67745_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00459-7","volume":"11","author":"RC Sterner","year":"2021","unstructured":"Sterner, R. C. & Sterner, R. M. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J. 11, 69 (2021).","journal-title":"Blood Cancer J."},{"key":"67745_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13045-022-01308-1","volume":"15","author":"X Jin","year":"2022","unstructured":"Jin, X. et al. First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed\/refractory acute myeloid leukemia. J. Hematol. Oncol. 15, 88 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"67745_CR8","doi-asserted-by":"crossref","unstructured":"Tambaro, F. P. et al. Autologous CD33-CAR-T cells for treatment of relapsed\/refractory acute myelogenous leukemia. Leukemia 35, 3282\u20133286 (2021).","DOI":"10.1038\/s41375-021-01232-2"},{"key":"67745_CR9","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/MOH.0000000000000190","volume":"22","author":"A Mardiros","year":"2015","unstructured":"Mardiros, A., Forman, S. J. & Budde, L. E. T cells expressing CD123 chimeric antigen receptors for treatment of acute myeloid leukemia. Curr. Opin. Hematol. 22, 484\u2013488 (2015).","journal-title":"Curr. Opin. Hematol."},{"key":"67745_CR10","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1038\/mt.2013.154","volume":"21","author":"DS Ritchie","year":"2013","unstructured":"Ritchie, D. S. et al. Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia. Mol. Ther. 21, 2122\u20132129 (2013).","journal-title":"Mol. Ther."},{"key":"67745_CR11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","volume":"24","author":"JA Fraietta","year":"2018","unstructured":"Fraietta, J. A. et al. Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nat. Med 24, 563\u2013571 (2018).","journal-title":"Nat. Med"},{"key":"67745_CR12","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1038\/s41591-020-1061-7","volume":"26","author":"Q Deng","year":"2020","unstructured":"Deng, Q. et al. Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas. Nat. Med 26, 1878\u20131887 (2020).","journal-title":"Nat. Med"},{"key":"67745_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03442-3","volume":"20","author":"T Kouro","year":"2022","unstructured":"Kouro, T., Himuro, H. & Sasada, T. Exhaustion of CAR T cells: potential causes and solutions. J. Transl. Med 20, 239 (2022).","journal-title":"J. Transl. Med"},{"key":"67745_CR14","doi-asserted-by":"publisher","first-page":"ra139","DOI":"10.1126\/scitranslmed.aac5415","volume":"7","author":"DL Porter","year":"2015","unstructured":"Porter, D. L. et al. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia. Sci. Transl. Med 7, ra139 (2015).","journal-title":"Sci. Transl. Med"},{"key":"67745_CR15","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1002\/eji.200425587","volume":"34","author":"N Kobayashi","year":"2004","unstructured":"Kobayashi, N., Takata, H., Yokota, S. & Takiguchi, M. Down-regulation of CXCR4 expression on human CD8+ T cells during peripheral differentiation. Eur. J. Immunol. 34, 3370\u20133378 (2004).","journal-title":"Eur. J. Immunol."},{"key":"67745_CR16","doi-asserted-by":"publisher","first-page":"10101","DOI":"10.1073\/pnas.0804286105","volume":"105","author":"RL Contento","year":"2008","unstructured":"Contento, R. L. et al. CXCR4-CCR5: a couple modulating T cell functions. Proc. Natl. Acad. Sci. USA 105, 10101\u201310106 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67745_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41417-021-00303-x","volume":"29","author":"K Kohli","year":"2022","unstructured":"Kohli, K., Pillarisetty, V. G. & Kim, T. S. Key chemokines direct migration of immune cells in solid tumors. Cancer Gene Ther. 29, 10\u201321 (2022).","journal-title":"Cancer Gene Ther."},{"key":"67745_CR18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/eji.201747438","volume":"49","author":"M Goedhart","year":"2019","unstructured":"Goedhart, M. et al. CXCR4, but not CXCR3, drives CD8(+) T-cell entry into and migration through the murine bone marrow. Eur. J. Immunol. 49, 576\u2013589 (2019).","journal-title":"Eur. J. Immunol."},{"key":"67745_CR19","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1016\/j.ymthe.2023.09.010","volume":"31","author":"R Sun","year":"2023","unstructured":"Sun, R. et al. CXCR4-modified CAR-T cells suppresses MDSCs recruitment via STAT3\/NF-kappaB\/SDF-1alpha axis to enhance efficacy against pancreatic cancer. Mol. Ther. 31, 3193\u20133209 (2023).","journal-title":"Mol. Ther."},{"key":"67745_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/CJI.0000000000000082","volume":"38","author":"N Muller","year":"2015","unstructured":"Muller, N. et al. Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12\/SDF-1alpha-secreting Glioblastoma. J. Immunother. 38, 197\u2013210 (2015).","journal-title":"J. Immunother."},{"key":"67745_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1383136","volume":"15","author":"MW Moles","year":"2024","unstructured":"Moles, M. W. et al. CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myeloma. Front Immunol. 15, 1383136 (2024).","journal-title":"Front Immunol."},{"key":"67745_CR22","first-page":"2587","volume":"141","author":"M Biondi","year":"2023","unstructured":"Biondi, M. et al. Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the acute myeloid leukemia burden. Blood 141, 2587\u20132598 (2023).","journal-title":"Blood"},{"key":"67745_CR23","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.4049\/jimmunol.170.9.4649","volume":"170","author":"T Ara","year":"2003","unstructured":"Ara, T. et al. A role of CXC chemokine ligand 12\/stromal cell-derived factor-1\/pre-B cell growth stimulating factor and its receptor CXCR4 in fetal and adult T cell development in vivo. J. Immunol. 170, 4649\u20134655 (2003).","journal-title":"J. Immunol."},{"key":"67745_CR24","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.4049\/jimmunol.1400488","volume":"193","author":"J Chaix","year":"2014","unstructured":"Chaix, J. et al. Cutting edge: CXCR4 is critical for CD8+ memory T cell homeostatic self-renewal but not rechallenge self-renewal. J. Immunol. 193, 1013\u20131016 (2014).","journal-title":"J. Immunol."},{"key":"67745_CR25","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1073\/pnas.94.5.1925","volume":"94","author":"CC Bleul","year":"1997","unstructured":"Bleul, C. C., Wu, L., Hoxie, J. A., Springer, T. A. & Mackay, C. R. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94, 1925\u20131930 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67745_CR26","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.4049\/jimmunol.160.9.4153","volume":"160","author":"P Jourdan","year":"1998","unstructured":"Jourdan, P. et al. IL-4 induces functional cell-surface expression of CXCR4 on human T cells. J. Immunol. 160, 4153\u20134157 (1998).","journal-title":"J. Immunol."},{"key":"67745_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1158\/2767-9764.CRC-21-0034","volume":"1","author":"M Ando","year":"2021","unstructured":"Ando, M. et al. Rejuvenating effector\/exhausted CAR T cells to stem cell memory-like CAR T cells by resting them in the presence of CXCL12 and the NOTCH ligand. Cancer Res Commun. 1, 41\u201355 (2021).","journal-title":"Cancer Res Commun."},{"key":"67745_CR28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","volume":"602","author":"JJ Melenhorst","year":"2022","unstructured":"Melenhorst, J. J. et al. Decade-long leukaemia remissions with persistence of CD4(+) CAR T cells. Nature 602, 503\u2013509 (2022).","journal-title":"Nature"},{"key":"67745_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/nm.4241","volume":"23","author":"L Gattinoni","year":"2017","unstructured":"Gattinoni, L., Speiser, D. E., Lichterfeld, M. & Bonini, C. T memory stem cells in health and disease. Nat. Med 23, 18\u201327 (2017).","journal-title":"Nat. Med"},{"key":"67745_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374, abe6474 (2021).","journal-title":"Science"},{"key":"67745_CR31","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ccell.2022.07.002","volume":"40","author":"D Bottomly","year":"2022","unstructured":"Bottomly, D. et al. Integrative analysis of drug response and clinical outcome in acute myeloid leukemia. Cancer Cell 40, 850\u2013864 e859 (2022).","journal-title":"Cancer Cell"},{"key":"67745_CR32","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","volume":"562","author":"JW Tyner","year":"2018","unstructured":"Tyner, J. W. et al. Functional genomic landscape of acute myeloid leukaemia. Nature 562, 526\u2013531 (2018).","journal-title":"Nature"},{"key":"67745_CR33","doi-asserted-by":"crossref","unstructured":"Saito, Y. et al. Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells. Sci Transl Med 2, 17ra19 (2010).","DOI":"10.1126\/scitranslmed.3000349"},{"key":"67745_CR34","doi-asserted-by":"publisher","first-page":"e0236124","DOI":"10.1371\/journal.pone.0236124","volume":"15","author":"J Li","year":"2020","unstructured":"Li, J. et al. Role of CD25 expression on prognosis of acute myeloid leukemia: A literature review and meta-analysis. PLoS One 15, e0236124 (2020).","journal-title":"PLoS One"},{"key":"67745_CR35","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1182\/blood-2012-02-414425","volume":"120","author":"M Gonen","year":"2012","unstructured":"Gonen, M. et al. CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900. Blood 120, 2297\u20132306 (2012).","journal-title":"Blood"},{"key":"67745_CR36","doi-asserted-by":"publisher","first-page":"11008","DOI":"10.1073\/pnas.0704271104","volume":"104","author":"N Hosen","year":"2007","unstructured":"Hosen, N. et al. CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia. Proc. Natl. Acad. Sci. USA 104, 11008\u201311013 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67745_CR37","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1038\/mt.2009.83","volume":"17","author":"MC Milone","year":"2009","unstructured":"Milone, M. C. et al. Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo. Mol. Ther. 17, 1453\u20131464 (2009).","journal-title":"Mol. Ther."},{"key":"67745_CR38","doi-asserted-by":"publisher","first-page":"e0194688","DOI":"10.1371\/journal.pone.0194688","volume":"13","author":"MJ Costa","year":"2018","unstructured":"Costa, M. J. et al. A mouse model for evaluation of efficacy and concomitant toxicity of anti-human CXCR4 therapeutics. PLoS One 13, e0194688 (2018).","journal-title":"PLoS One"},{"key":"67745_CR39","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1038\/leu.2017.57","volume":"31","author":"D Sommermeyer","year":"2017","unstructured":"Sommermeyer, D. et al. Fully human CD19-specific chimeric antigen receptors for T-cell therapy. Leukemia 31, 2191\u20132199 (2017).","journal-title":"Leukemia"},{"key":"67745_CR40","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","volume":"17","author":"S Rafiq","year":"2020","unstructured":"Rafiq, S., Hackett, C. S. & Brentjens, R. J. Engineering strategies to overcome the current roadblocks in CAR T cell therapy. Nat. Rev. Clin. Oncol. 17, 147\u2013167 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"67745_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.944248","volume":"12","author":"DD Liu","year":"2022","unstructured":"Liu, D. D. et al. Umbilical cord blood: a promising source for allogeneic CAR-T cells. Front Oncol. 12, 944248 (2022).","journal-title":"Front Oncol."},{"key":"67745_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1561174","volume":"16","author":"K Rassek","year":"2025","unstructured":"Rassek, K. et al. New player in CAR-T manufacture field: comparison of umbilical cord to peripheral blood strategies. Front Immunol. 16, 1561174 (2025).","journal-title":"Front Immunol."},{"key":"67745_CR43","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jim.2018.10.014","volume":"464","author":"M Tanaka","year":"2019","unstructured":"Tanaka, M. et al. Development of a simple new flow cytometric antibody-dependent cellular cytotoxicity (ADCC) assay with excellent sensitivity. J. Immunol. Methods 464, 74\u201386 (2019).","journal-title":"J. Immunol. Methods"},{"key":"67745_CR44","first-page":"165 e161","volume":"29","author":"JA Read","year":"2023","unstructured":"Read, J. A., Rouce, R. H., Mo, F., Mamonkin, M. & King, K. Y. Apoptosis of hematopoietic stem cells contributes to bone marrow suppression following chimeric antigen receptor T cell therapy. Transpl. Cell Ther. 29, 165 e161\u2013165 e167 (2023).","journal-title":"Transpl. Cell Ther."},{"key":"67745_CR45","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41417-021-00365-x","volume":"29","author":"YY Ng","year":"2022","unstructured":"Ng, Y. Y., Du, Z., Zhang, X., Chng, W. J. & Wang, S. CXCR4 and anti-BCMA CAR co-modified natural killer cells suppress multiple myeloma progression in a xenograft mouse model. Cancer Gene Ther. 29, 475\u2013483 (2022).","journal-title":"Cancer Gene Ther."},{"key":"67745_CR46","unstructured":"Renart-Depontieu, F. et al., Florence RENART-DEPONTIEUSachiko TAKAMIGermain MARGALL-DUCOSNicola BeltraminelliPierre GarroneAnne ROGELAymen Al-ShamkhaniXavier Preville. inventors; Cd96-binding agents as immunomodulators (WO2019030377A1). (2018)."},{"key":"67745_CR47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cyto.2016.08.003","volume":"101","author":"AK Mehta","year":"2018","unstructured":"Mehta, A. K., Gracias, D. T. & Croft, M. TNF activity and T cells. Cytokine 101, 14\u201318 (2018).","journal-title":"Cytokine"},{"key":"67745_CR48","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1172\/JCI128672","volume":"130","author":"ZT Freeman","year":"2020","unstructured":"Freeman, Z. T. et al. A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target. J. Clin. Invest 130, 1405\u20131416 (2020).","journal-title":"J. Clin. Invest"},{"key":"67745_CR49","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1182\/bloodadvances.2021006195","volume":"6","author":"J Swatler","year":"2022","unstructured":"Swatler, J. et al. 4-1BBL-containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells. Blood Adv. 6, 1879\u20131894 (2022).","journal-title":"Blood Adv."},{"key":"67745_CR50","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1073\/pnas.0511137103","volume":"103","author":"CJ Luckey","year":"2006","unstructured":"Luckey, C. J. et al. Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 103, 3304\u20133309 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67745_CR51","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.celrep.2016.06.078","volume":"16","author":"A Schurich","year":"2016","unstructured":"Schurich, A. et al. Distinct metabolic requirements of exhausted and functional virus-specific CD8 T cells in the same host. Cell Rep. 16, 1243\u20131252 (2016).","journal-title":"Cell Rep."},{"key":"67745_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.645242","volume":"12","author":"GO Rangel Rivera","year":"2021","unstructured":"Rangel Rivera, G. O. et al. Fundamentals of T cell metabolism and strategies to enhance cancer immunotherapy. Front Immunol. 12, 645242 (2021).","journal-title":"Front Immunol."},{"key":"67745_CR53","doi-asserted-by":"crossref","unstructured":"Chen, Y. & Gaber, T. Hypoxia\/HIF modulates immune responses. Biomedicines 9, 260 (2021).","DOI":"10.3390\/biomedicines9030260"},{"key":"67745_CR54","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.cmet.2018.02.024","volume":"27","author":"T Cascone","year":"2018","unstructured":"Cascone, T. et al. Increased tumor glycolysis characterizes immune resistance to adoptive T cell therapy. Cell Metab. 27, 977\u2013987 e974 (2018).","journal-title":"Cell Metab."},{"key":"67745_CR55","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1002\/ijc.25543","volume":"128","author":"K Singer","year":"2011","unstructured":"Singer, K. et al. Warburg phenotype in renal cell carcinoma: high expression of glucose-transporter 1 (GLUT-1) correlates with low CD8(+) T-cell infiltration in the tumor. Int J. Cancer 128, 2085\u20132095 (2011).","journal-title":"Int J. Cancer"},{"key":"67745_CR56","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fimmu.2017.00248","volume":"8","author":"K Renner","year":"2017","unstructured":"Renner, K. et al. Metabolic hallmarks of tumor and immune cells in the tumor microenvironment. Front Immunol. 8, 248 (2017).","journal-title":"Front Immunol."},{"key":"67745_CR57","doi-asserted-by":"crossref","unstructured":"Weber, E. W. et al. Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling. Science 372, eaba1786 (2021).","DOI":"10.1126\/science.aba1786"},{"key":"67745_CR58","doi-asserted-by":"publisher","first-page":"1034257","DOI":"10.3389\/fcell.2022.1034257","volume":"10","author":"X Zhu","year":"2022","unstructured":"Zhu, X., Li, Q. & Zhu, X. Mechanisms of CAR T cell exhaustion and current counteraction strategies. Front Cell Dev. Biol. 10, 1034257 (2022).","journal-title":"Front Cell Dev. Biol."},{"key":"67745_CR59","doi-asserted-by":"publisher","first-page":"878209","DOI":"10.3389\/fimmu.2022.878209","volume":"13","author":"G Lopez-Cantillo","year":"2022","unstructured":"Lopez-Cantillo, G., Uruena, C., Camacho, B. A. & Ramirez-Segura, C. CAR-T Cell Performance: How to Improve Their Persistence? Front Immunol. 13, 878209 (2022).","journal-title":"Front Immunol."},{"key":"67745_CR60","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1182\/blood.2022016204","volume":"141","author":"W Qasim","year":"2023","unstructured":"Qasim, W. Genome-edited allogeneic donor \u201cuniversal\u201d chimeric antigen receptor T cells. Blood 141, 835\u2013845 (2023).","journal-title":"Blood"},{"key":"67745_CR61","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba1624","volume":"378","author":"GM Allen","year":"2022","unstructured":"Allen, G. M. et al. Synthetic cytokine circuits that drive T cells into immune-excluded tumors. Science 378, eaba1624 (2022).","journal-title":"Science"},{"key":"67745_CR62","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nbt.4086","volume":"36","author":"K Adachi","year":"2018","unstructured":"Adachi, K. et al. IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor. Nat. Biotechnol. 36, 346\u2013351 (2018).","journal-title":"Nat. Biotechnol."},{"key":"67745_CR63","doi-asserted-by":"crossref","unstructured":"Guedan, S. et al. Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation. JCI Insight 3, e96976 (2018).","DOI":"10.1172\/jci.insight.96976"},{"key":"67745_CR64","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1056\/NEJMoa1602074","volume":"375","author":"F Milano","year":"2016","unstructured":"Milano, F. et al. Cord-blood transplantation in patients with minimal residual disease. N. Engl. J. Med 375, 944\u2013953 (2016).","journal-title":"N. Engl. J. Med"},{"key":"67745_CR65","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/s13287-022-03110-9","volume":"13","author":"Y Sun","year":"2022","unstructured":"Sun, Y., Zhao, J., Zhang, L., Li, Z. & Lei, S. Effectiveness and safety of stem cell therapy for diabetic foot: a meta-analysis update. Stem Cell Res Ther. 13, 416 (2022).","journal-title":"Stem Cell Res Ther."},{"key":"67745_CR66","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1182\/bloodadvances.2020001737","volume":"4","author":"P Hiwarkar","year":"2020","unstructured":"Hiwarkar, P. et al. Cord blood CD8+ T-cell expansion following granulocyte transfusions eradicates refractory leukemia. Blood Adv. 4, 4165\u20134174 (2020).","journal-title":"Blood Adv."},{"key":"67745_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/srep37827","volume":"6","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. CXCR4\/CXCL12 axis counteracts hematopoietic stem cell exhaustion through selective protection against oxidative stress. Sci. Rep. 6, 37827 (2016).","journal-title":"Sci. Rep."},{"key":"67745_CR68","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1182\/blood-2010-01-266833","volume":"117","author":"YS Tzeng","year":"2011","unstructured":"Tzeng, Y. S. et al. Loss of Cxcl12\/Sdf-1 in adult mice decreases the quiescent state of hematopoietic stem\/progenitor cells and alters the pattern of hematopoietic regeneration after myelosuppression. Blood 117, 429\u2013439 (2011).","journal-title":"Blood"},{"key":"67745_CR69","doi-asserted-by":"crossref","unstructured":"Enbar, T. & Tang, L. Mimicking the TCR immune synapse for improved CAR-T cell function. Cell Res. 35, 549\u2013550 (2025).","DOI":"10.1038\/s41422-025-01086-8"},{"key":"67745_CR70","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.ymthe.2018.01.020","volume":"26","author":"W Xiong","year":"2018","unstructured":"Xiong, W. et al. Immunological synapse predicts effectiveness of chimeric antigen receptor cells. Mol. Ther. 26, 963\u2013975 (2018).","journal-title":"Mol. Ther."},{"key":"67745_CR71","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/imm.12065","volume":"139","author":"JS Ellis","year":"2013","unstructured":"Ellis, J. S., Wan, X. & Braley-Mullen, H. Transient depletion of CD4+ CD25+ regulatory T cells results in multiple autoimmune diseases in wild-type and B-cell-deficient NOD mice. Immunology 139, 179\u2013186 (2013).","journal-title":"Immunology"},{"key":"67745_CR72","doi-asserted-by":"publisher","first-page":"102376","DOI":"10.1016\/j.jaut.2019.102376","volume":"110","author":"C Scheinecker","year":"2020","unstructured":"Scheinecker, C., Goschl, L. & Bonelli, M. Treg cells in health and autoimmune diseases: New insights from single cell analysis. J. Autoimmun. 110, 102376 (2020).","journal-title":"J. Autoimmun."},{"key":"67745_CR73","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s43018-020-00133-0","volume":"1","author":"I Solomon","year":"2020","unstructured":"Solomon, I. et al. CD25-T(reg)-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity. Nat. Cancer 1, 1153\u20131166 (2020).","journal-title":"Nat. Cancer"},{"key":"67745_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-02449-y","volume":"11","author":"D Song","year":"2021","unstructured":"Song, D. et al. Two novel human anti-CD25 antibodies with antitumor activity inversely related to their affinity and in vitro activity. Sci. Rep. 11, 22966 (2021).","journal-title":"Sci. Rep."},{"key":"67745_CR75","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.msard.2016.05.010","volume":"9","author":"G Giovannoni","year":"2016","unstructured":"Giovannoni, G. et al. Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies. Mult. Scler. Relat. Disord. 9, 36\u201346 (2016).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"67745_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00822-w","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies. Blood Cancer J. 13, 61 (2023).","journal-title":"Blood Cancer J."},{"key":"67745_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66806-z","volume":"10","author":"F Liu","year":"2020","unstructured":"Liu, F. et al. CD96, a new immune checkpoint, correlates with immune profile and clinical outcome of glioma. Sci. Rep. 10, 10768 (2020).","journal-title":"Sci. Rep."},{"key":"67745_CR78","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.12688\/f1000research.26073.1","volume":"9","author":"HL Crowell","year":"2020","unstructured":"Crowell, H. L. et al. An R-based reproducible and user-friendly preprocessing pipeline for CyTOF data. F1000Res 9, 1263 (2020).","journal-title":"F1000Res"},{"key":"67745_CR79","doi-asserted-by":"publisher","first-page":"748","DOI":"10.12688\/f1000research.11622.1","volume":"6","author":"M Nowicka","year":"2017","unstructured":"Nowicka, M. et al. CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets. F1000Res 6, 748 (2017).","journal-title":"F1000Res"},{"key":"67745_CR80","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/nbt1350","volume":"25","author":"F Ishikawa","year":"2007","unstructured":"Ishikawa, F. et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat. Biotechnol. 25, 1315\u20131321 (2007).","journal-title":"Nat. Biotechnol."},{"key":"67745_CR81","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2016.01.012","volume":"164","author":"L Morsut","year":"2016","unstructured":"Morsut, L. et al. Engineering customized cell sensing and response behaviors using synthetic notch receptors. Cell 164, 780\u2013791 (2016).","journal-title":"Cell"},{"key":"67745_CR82","unstructured":"Cameron, J. T., Roland, B. W., George, S. & Laszlo, S. F. Chimeric antigen receptors targeting CD33. https:\/\/patents.google.com\/patent\/US20230220103A1\/en?oq=US20230220103Al+CD33 (2023)."},{"key":"67745_CR83","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"67745_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41695-z","volume":"9","author":"VA Traag","year":"2019","unstructured":"Traag, V. A., Waltman, L. & van Eck, N. J. From Louvain to Leiden: guaranteeing well-connected communities. Sci. Rep. 9, 5233 (2019).","journal-title":"Sci. Rep."},{"key":"67745_CR85","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"67745_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27729-z","volume":"13","author":"GC Linderman","year":"2022","unstructured":"Linderman, G. C. et al. Zero-preserving imputation of single-cell RNA-seq data. Nat. Commun. 13, 192 (2022).","journal-title":"Nat. Commun."},{"key":"67745_CR87","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41586-022-04571-x","volume":"604","author":"V Calvanese","year":"2022","unstructured":"Calvanese, V. et al. Mapping human haematopoietic stem cells from haemogenic endothelium to birth. Nature 604, 534\u2013540 (2022).","journal-title":"Nature"},{"key":"67745_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13983-9","volume":"11","author":"M Paczkowska","year":"2020","unstructured":"Paczkowska, M. et al. Integrative pathway enrichment analysis of multivariate omics data. Nat. Commun. 11, 735 (2020).","journal-title":"Nat. Commun."},{"key":"67745_CR89","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/nmeth983","volume":"3","author":"DJ Fitzgerald","year":"2006","unstructured":"Fitzgerald, D. J. et al. Protein complex expression by using multigene baculoviral vectors. Nat. Methods 3, 1021\u20131032 (2006).","journal-title":"Nat. Methods"},{"key":"67745_CR90","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"67745_CR91","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"67745_CR92","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4792","volume":"32","author":"EC Meng","year":"2023","unstructured":"Meng, E. C. et al. UCSF ChimeraX: tools for structure building and analysis. Protein Sci. 32, e4792 (2023).","journal-title":"Protein Sci."},{"key":"67745_CR93","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1107\/S2059798318002425","volume":"74","author":"TI Croll","year":"2018","unstructured":"Croll, T. I. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr D. Struct. Biol. 74, 519\u2013530 (2018).","journal-title":"Acta Crystallogr D. Struct. Biol."},{"key":"67745_CR94","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr D. Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr D. Struct. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67745-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67745-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67745-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T10:02:39Z","timestamp":1769421759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67745-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67745"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67745-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}